Related Experiment Video
Updated: Oct 26, 2025
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
A correlation analysis of the serum hepcidin concentrations and viral loads in HCV-infected patients
Rongqi Wang1, Suxian Zhao1, Jinghua Du1
1Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University Shijiazhuang 050051, Hebei, China.
Insights
Hepatitis C virus (HCV) infection is linked to lower serum hepcidin levels, indicating potential iron metabolism disorders. Measuring hepcidin may help assess HCV patient conditions and improve prognoses by managing iron levels.
Area of Science:
- Hepatology
- Virology
- Biochemistry
Background:
- Hepatitis C virus (HCV) infection can lead to liver damage and altered iron metabolism.
- Hepcidin is a key regulator of iron homeostasis, and its levels may be affected in chronic infections.
Purpose of the Study:
- To investigate the correlation between serum hepcidin levels and viral loads in patients with HCV infection.
- To explore the relationship between hepcidin levels and liver inflammation markers in HCV patients.
Main Methods:
- A cohort of 60 HCV-infected patients and 50 healthy controls were analyzed.
- Serum hepcidin, iron, ferritin, transferrin, and liver function parameters were measured.
- Correlations between viral markers (HCV-RNA, HCV Ag, HCV Ab) and hepcidin levels were assessed.
Main Results:
- HCV patients exhibited significantly lower serum hepcidin, transferrin, and albumin levels compared to controls.
- Higher viral loads (HCV-RNA, HCV Ag, HCV Ab) were negatively correlated with serum hepcidin levels.
- Hepcidin levels were lower in patients with more severe liver inflammation (G3-G4) compared to mild cases (G1-G2).
Conclusions:
- Decreased serum hepcidin levels in HCV patients suggest an iron metabolism disorder.
- Measuring hepcidin may aid in evaluating the condition of HCV patients.
- Regulating iron metabolism could potentially improve prognoses for individuals with HCV.
Objective:
To investigate the correlation between the serum hepcidin levels and the viral loads in hepatitis C virus (HCV) infected patients.
Methods:
Sixty HCV-infected patients (the study group) and 50 healthy controls (the control group) were recruited as the study cohort. The liver function and inflammation-related parameters were compared, and the 60 HCV patients were divided into mild (G1-G2), moderate (G3), and severe (G4) groups according to each patient's inflammatory activity grade (G). The serum iron (SI), ferritin (SF), and transferrin (TRF), hepcidin levels were compared. The relationships between the HCV-RNA, HCV Ag, HCV Ab, albumin (ALB), total bilirubin (TBIL), aminotransferase (ALT), and aspartate aminotransferase (AST) levels and the hepcidin levels was analyzed. The SI, SF, IL-6, ALT, AST, and TBIL levels were significantly higher, and the hepcidin, TRF, and ALB levels were significantly lower in the study group than they were in the control group (P<0.05). The G4 patients' SI and SF levels were significantly higher than they were in the G3 and the G1-G2 groups (P<0.05). The TRF and hepcidin levels in the G1-G2 group were significantly higher than they were in the G3 and G4 groups (P<0.05). The HCV-RNA, HCV Ag, and HCV Ab levels were negatively correlated with the hepcidin levels (r=-0.7679, r=-0.9062, r=-0.6095, P<0.05), positively correlated with the serum ALB, TBIL, and ALT levels (r=0.9792, r=0.9759, r=0.8236, P<0.05), and not significantly correlated with the AST levels (r=-0.2803, P>0.05).
Conclusion:
The HCV patients' serum hepcidin levels showed an abnormal decrease, suggesting that HCV patients may have an iron metabolism disorder, which indicates that there is a possibility of evaluating the HCV patients' conditions by measuring the hepcidin levels and of improving HCV patients' prognoses by regulating the iron metabolism.
